Pilot study of hydrolytically activated paclitaxel prodrug therapy in patients with progressive malignancies
- 1 April 2002
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 63 (4) , 247-262
- https://doi.org/10.1016/s0011-393x(02)80030-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Post-operative adjuvant therapy for non-small-cell lung cancer.Lung Cancer, 1997
- Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.Proceedings of the National Academy of Sciences, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Phase II Trial of Taxol in Patients with Metastatic Renal Cell CarcinomaCancer Investigation, 1991
- Taxol: Mechanisms of Action and ResistanceaAnnals of the New York Academy of Sciences, 1986
- Taxol binds to cellular microtubules.The Journal of cell biology, 1982
- Promotion of microtubule assembly in vitro by taxolNature, 1979